NASDAQ-Listed Cannabis Giant Misses Tech Rally: What Investors Need To Know About MAPS’ Stock

Valued at 1.2x sales and 12.8x EBITDA, MAPS currently lags behind peers in the tech sector, with non-cannabis marketplace stocks trading at 2.6x sales, e-commerce enablement platforms at 3.6x and …